Search results
Results from the WOW.Com Content Network
This page was last edited on 8 February 2024, at 12:44 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.
Naltrexone, sold under the brand name Revia among others, is a medication primarily used to manage alcohol use or opioid use disorder by reducing cravings and feelings of euphoria associated with substance use disorder. [8] It has also been found effective in the treatment of other addictions and may be used for them off-label. [12]
Multiple studies have shown that low-dose naltrexone has promise as a treatment for chronic pain, some autoimmune disorders and cancers. [8] [9] [10] As of 2014, no peer-reviewed studies supporting low-dose naltrexone for multiple sclerosis (MS) have been published. [11] [12] Clinical trials for treatment of fibromyalgia were initiated in 2021 ...
m e m o r a n d u m department of health and human services public health service food and drug administration center for drug evaluation and research
%PDF-1.3 %Äåòåë§ó ÐÄÆ 4 0 obj /Length 5 0 R /Filter /FlateDecode >> stream x ¥ZÛrÛF }ÇWôÆ/d c .©ÍVYÞu ç²NI ...
Naltrexone/bupropion, sold under the brand name Contrave among others, is a fixed-dose combination medication for the management of chronic obesity in adults in combination with a reduced-calorie diet and increased physical activity. [4] [6] It contains naltrexone, an opioid antagonist, and bupropion, an aminoketone atypical antidepressant. [4]
Nalmefene, sold under the brand name Revex among others, is a medication that is used in the treatment of opioid overdose and alcohol dependence. [2] [3] Nalmefene belongs to the class of opioid antagonists and can be taken by mouth, administered by injection, or delivered through nasal administration.
(+)-Naloxone (dextro-naloxone) is a drug which is the opposite enantiomer of the opioid antagonist drug (−)-naloxone.Unlike (−)-naloxone, (+)-naloxone has no significant affinity for opioid receptors, [1] but instead has been discovered to act as a selective antagonist of Toll-like receptor 4.